More researchers continue to assess the prognostic role of serum GGT in cervical cancer (43), esophageal squamous cell carcinoma (44), ovarian cancer (45), renal cell carcinoma (25), and HCC (46). The gene discussed is GGT1; the disease is hereditary clear cell renal cell carcinoma.